Awareness of Chinese National Adult Lipid Treatment Guideline (2007) and rate of patients achieving the treatment goal - CRE NIS
Study identifier:NIS-CCN-CRE-2008/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A cross-sectional study to survey the awareness of Chinese National Adult Lipid Treatment Guideline (2007) and the rate of patients (on treatment) achieving the hyperlipidaemia treatment goal with Crestor 5mg to 10mg for 8 weeks
Medical condition
hyperlipidemia
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
2575
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Oct 2008
Primary Completion Date: -
Study Completion Date: 01 Jul 2009
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 patients being diagnosed as dyslipidemia but not receiving Crestor® | - |
| 2 hypercholesterolemia or mixed dyslipidemia and have been initiated treatment with Crestor® | - |
Contacts
Investigators
Principal Investigator
Karen Atkin
Astrazeneca China R&D
